Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis

Shu-Han Liu,Xiao-Jie Shi,Fang-Cheng Fan,Yong Cheng
DOI: https://doi.org/10.1038/s41598-020-79080-w
IF: 4.6
2021-01-08
Scientific Reports
Abstract:Abstract Increasing evidence suggests that abnormal regulation of neurotrophic factors is involved in the etiology and pathogenesis of Autism Spectrum Disorder (ASD). However, clinical data on neurotrophic factor levels in children with ASD were inconsistent. Therefore, we performed a systematic review of peripheral blood neurotrophic factors levels in children with ASD, and quantitatively summarized the clinical data of peripheral blood neurotrophic factors in ASD children and healthy controls. A systematic search of PubMed and Web of Science identified 31 studies with 2627 ASD children and 4418 healthy controls to be included in the meta-analysis. The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges’ g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges’ g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges’ g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with ASD were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges’ g = − 0.795; 95% CI = − 1.723 to 0.134; P = 0.093) and neurotrophin-4 (Hedges’ g = 0.182; 95% CI = − 0.285 to 0.650; P = 0.445) levels did not show significant differences between cases and controls. Taken together, these results clarified circulating neurotrophic factor profile in children with ASD, strengthening clinical evidence of neurotrophic factor aberrations in children with ASD.
multidisciplinary sciences
What problem does this paper attempt to address?
The paper primarily explores the changes in the levels of neurotrophic factors in the peripheral blood of children with Autism Spectrum Disorder (ASD). The researchers conducted a systematic review and meta-analysis to quantitatively summarize the clinical data on peripheral blood neurotrophic factor levels between children with ASD and healthy control groups. Specifically, the researchers retrieved relevant literature from the PubMed and Web of Science databases and ultimately included 31 studies in the meta-analysis. These studies involved a total of 2627 children with ASD and 4418 healthy control individuals. The results of the meta-analysis showed: - The levels of Brain-Derived Neurotrophic Factor (BDNF), Nerve Growth Factor (NGF), and Vascular Endothelial Growth Factor (VEGF) in the peripheral blood of children with ASD were significantly higher than those in the healthy control group. - However, for Neurotrophin-3 (NT-3) and Neurotrophin-4 (NT-4), there were no significant differences in serum levels between children with ASD and the healthy control group. The study results help clarify the profile of neurotrophic factors in children with ASD and provide stronger clinical evidence for the abnormalities of neurotrophic factors in ASD. Additionally, the study explored the sources of heterogeneity among different neurotrophic factors and assessed potential influencing factors through subgroup analysis and meta-regression analysis.